Patent details

EP2915525 Title: Sublingual abuse-resistant tablets comprising buprenorphine and naloxone

Basic Information

Publication number:
EP2915525
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP151560240
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
Sublingual abuse-resistant tablets comprising buprenorphine and naloxone
French Title of Invention:
Comprimés résistant aux abus à administration sublinguale contenant de la buprénorphine et de la naloxone
German Title of Invention:
Mißbrauchssichere Sublingualtabletten enthaltend Buprenorphin und Naloxon
SPC Number:

Dates

Filing date:
18/09/2012
Grant date:
11/08/2021
EP Publication Date:
09/09/2015
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
11/08/2021
EP B1 Publication Date:
11/08/2021
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
18/09/2032
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
04/08/2021
 
 

Name:
Orexo AB
Address:
Box 303, 751 05 Uppsala, Sweden (SE)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
19/08/2021
Address:
Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
To:

Inventor

Name:
Fischer, Andreas
Address:
Sweden (SE)

Priority

Priority Number:
201161536180 P
Priority Date:
19/09/2011
Priority Country:
United States (US)

Classification

IPC classification:
A61K 9/00; A61K 31/485; A61K 9/20; A61K 31/4748; A61P 25/04; A61P 25/30; A61P 25/36;

Publication

European Patent Bulletin

1

Issue number:
202132
Publication date:
11/08/2021
Description:
Grant (B1)

2

Issue number:
202137
Publication date:
15/09/2021
Description:
Application number/publication number of the divisional application (Art. 76) changed

Annual Fees

Annual Fee Due Date:
30/09/2026
Annual Fee Number:
15
Annual Fee Amount:
213 Euro
Expected Payer:
Last Annual Fee Payment Date:
23/09/2025
Last Annual Fee Paid Number:
14
Last Annual Fee Paid Amount:
198 Euro
Payer:
IPIFY SAS
Filing date Document type Number of pages
19/08/2021 Outgoing Correspondence 1
19/08/2021 Power Of Attorney 1